Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M42.0Revenue $M0.2Net Margin (%)-3,184.4Z-Score4.6
Enterprise Value $M17.6EPS $-2.4Operating Margin %-3,295.6F-Score2
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-3,251.9Higher ROA y-yY
Price/Book1.810-y EBITDA Growth Rate %-37.1Quick Ratio12.9Cash flow > EarningsY
Price/Sales95.35-y EBITDA Growth Rate %-65.7Current Ratio12.9Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-49.8Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-54.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M10.5ROI % (ttm)-70.6Gross Margin Increase y-yN

Gurus Latest Trades with ROSG

Number of guru portfolios checked: 56.

No Entry found!

ROSG is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ROSG: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about ROSG :

    Quarterly/Annual Reports about ROSG:

      News about ROSG:

      Articles On GuruFocus.com
      Rosetta Genomics Reports Second Quarter Financial Results, Provides Business Update Sep 08 2009 
      Rosetta Genomics Announces Exclusive Distribution Agreement With Teva Pharmaceutical Industries Ltd. Jan 08 2009 
      Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $ Dec 08 2008 

      More From Other Websites
      Rosetta Genomics Receives Final New York State Approval for Rosetta Kidney Cancer Test Jul 22 2014
      Rosetta Genomics Receives Final New York State Approval for Rosetta Kidney Cancer Test Jul 22 2014
      9:30 am Rosetta Genomics receives final New York State approval for Rosetta kidney cancer test Jul 22 2014
      Nasdaq stocks posting largest volume increases Jul 21 2014
      Rosetta Genomics Receives Notice of Allowance for U.S. Patent for the Treatment of Ovarian Cancer Jul 10 2014
      Rosetta Genomics Receives Notice of Allowance for U.S. Patent for the Treatment of Ovarian Cancer Jul 10 2014
      ROSG: Collaboration Accelerates Product Development and Represents New Avenue for Revenue Growth Jun 27 2014
      Rosetta Genomics Receives Notice of Allowance for U.S. Patent for the Prognosis and Treatment of... Jun 26 2014
      UPDATE: Rosetta Genomics and Moffitt Cancer Center Enter Into Agreement to Advance Development of... Jun 09 2014
      Rosetta, Moffitt enter into agreement for thyroid neoplasia assay Jun 09 2014
      Rosetta Genomics and Moffitt Cancer Center Enter Into Agreement to Advance Development of... Jun 09 2014
      UPDATE: Barrington Research Initiates Coverage On Rosetta Genomics Ltd. On Good Market Position Jun 04 2014
      ROSETTA GENOMICS LTD. Financials Apr 05 2014
      Rosetta Genomics to Receive U.S. Patent for Cancer Origin Assay Apr 04 2014
      Rosetta Genomics and Marina Biotech Establish Strategic Alliance to Jointly Develop microRNA-Based... Apr 02 2014
      ROSG: Three Platforms Will Drive Revenue Growth in 2014 and Beyond Apr 02 2014
      Full Year 2013 Rosetta Genomics Ltd Earnings Call scheduled for 10:00 am ET today Apr 01 2014
      Rosetta Genomics Reports 2013 Financial Results Mar 31 2014
      Rosetta Genomics to Host Business Update Conference Call on April 1, 2014 Mar 25 2014
      Rosetta Genomics to Host Business Update Conference Call on April 1, 2014 Mar 25 2014

      Add Notes, Comments or Ask Questions

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK
      Email Hide